PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BlackRock Health Sciences Trust II (BMEZ)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS09260E1055
CUSIP09260E105
SectorFinancial Services
IndustryCapital Markets
IPO DateJan 29, 2020

Highlights

Market Cap$1.64B
EPS (TTM)-$0.16
Year Range$12.34 - $16.09
Short %0.44%
Short Ratio0.89

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons: BMEZ vs. BME, BMEZ vs. BSTZ, BMEZ vs. HELX, BMEZ vs. VVR, BMEZ vs. VHT, BMEZ vs. MRK, BMEZ vs. O, BMEZ vs. JEPI, BMEZ vs. ARKG, BMEZ vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in BlackRock Health Sciences Trust II, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%JuneJulyAugustSeptemberOctoberNovember
10.14%
13.00%
BMEZ (BlackRock Health Sciences Trust II)
Benchmark (^GSPC)

Returns By Period

BlackRock Health Sciences Trust II had a return of 16.95% year-to-date (YTD) and 26.59% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date16.95%25.48%
1 month-0.02%2.14%
6 months9.85%12.76%
1 year26.59%33.14%
5 years (annualized)N/A13.96%
10 years (annualized)N/A11.39%

Monthly Returns

The table below presents the monthly returns of BMEZ, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20245.82%6.45%1.05%-11.32%6.31%1.77%5.09%1.75%-0.28%-1.49%16.95%
20238.48%-3.24%6.02%-1.90%-2.21%5.19%0.40%-4.59%-5.81%-8.56%7.00%5.99%5.07%
2022-14.31%-5.59%-0.16%-12.19%-3.43%-0.83%4.33%-3.19%-7.64%5.52%5.46%-4.47%-32.65%
20211.18%-5.43%-2.90%5.21%3.42%2.70%-1.45%1.84%-5.65%-0.32%-8.71%5.33%-5.77%
20201.40%-1.57%-10.50%9.96%3.59%4.15%8.57%8.11%-1.55%-1.59%17.43%5.11%48.75%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of BMEZ is 81, placing it in the top 19% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of BMEZ is 8181
Combined Rank
The Sharpe Ratio Rank of BMEZ is 8989Sharpe Ratio Rank
The Sortino Ratio Rank of BMEZ is 8787Sortino Ratio Rank
The Omega Ratio Rank of BMEZ is 8484Omega Ratio Rank
The Calmar Ratio Rank of BMEZ is 6666Calmar Ratio Rank
The Martin Ratio Rank of BMEZ is 8282Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for BlackRock Health Sciences Trust II (BMEZ) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


BMEZ
Sharpe ratio
The chart of Sharpe ratio for BMEZ, currently valued at 2.05, compared to the broader market-4.00-2.000.002.004.002.05
Sortino ratio
The chart of Sortino ratio for BMEZ, currently valued at 2.86, compared to the broader market-4.00-2.000.002.004.006.002.86
Omega ratio
The chart of Omega ratio for BMEZ, currently valued at 1.36, compared to the broader market0.501.001.502.001.36
Calmar ratio
The chart of Calmar ratio for BMEZ, currently valued at 0.67, compared to the broader market0.002.004.006.000.67
Martin ratio
The chart of Martin ratio for BMEZ, currently valued at 7.43, compared to the broader market0.0010.0020.0030.007.43
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.91, compared to the broader market-4.00-2.000.002.004.002.91
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.88, compared to the broader market-4.00-2.000.002.004.006.003.88
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.55, compared to the broader market0.501.001.502.001.55
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 4.20, compared to the broader market0.002.004.006.004.20
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 18.80, compared to the broader market0.0010.0020.0030.0018.80

Sharpe Ratio

The current BlackRock Health Sciences Trust II Sharpe ratio is 2.05. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of BlackRock Health Sciences Trust II with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50JuneJulyAugustSeptemberOctoberNovember
2.05
2.91
BMEZ (BlackRock Health Sciences Trust II)
Benchmark (^GSPC)

Dividends

Dividend History

BlackRock Health Sciences Trust II provided a 9.07% dividend yield over the last twelve months, with an annual payout of $1.43 per share.


4.00%6.00%8.00%10.00%12.00%$0.00$0.50$1.00$1.502020202120222023
Dividends
Dividend Yield
PeriodTTM2023202220212020
Dividend$1.43$1.58$1.74$1.71$0.90

Dividend yield

9.07%10.81%11.28%6.75%3.14%

Monthly Dividends

The table displays the monthly dividend distributions for BlackRock Health Sciences Trust II. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.09$0.09$0.09$0.09$0.09$0.18$0.18$0.18$0.18$0.18$0.00$1.34
2023$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.09$0.09$0.09$1.58
2022$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$1.74
2021$0.10$0.10$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.21$1.71
2020$0.10$0.10$0.10$0.10$0.10$0.10$0.10$0.10$0.10$0.90

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-27.65%
-0.27%
BMEZ (BlackRock Health Sciences Trust II)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the BlackRock Health Sciences Trust II. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BlackRock Health Sciences Trust II was 46.05%, occurring on May 11, 2022. The portfolio has not yet recovered.

The current BlackRock Health Sciences Trust II drawdown is 27.65%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-46.05%Feb 16, 2021313May 11, 2022
-39.45%Feb 12, 202025Mar 18, 202075Jul 6, 2020100
-9.99%Sep 2, 20204Sep 8, 202019Oct 5, 202023
-8.46%Oct 14, 202013Oct 30, 20204Nov 5, 202017
-8.29%Jan 21, 20218Feb 1, 20219Feb 12, 202117

Volatility

Volatility Chart

The current BlackRock Health Sciences Trust II volatility is 3.70%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JuneJulyAugustSeptemberOctoberNovember
3.70%
3.75%
BMEZ (BlackRock Health Sciences Trust II)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of BlackRock Health Sciences Trust II over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for BlackRock Health Sciences Trust II.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items